This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Resumen de acción ABMD
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de Abiomed, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$381.02 |
| 52 Week High | US$381.99 |
| 52 Week Low | US$219.85 |
| Beta | 1.4 |
| 1 Month Change | 0.86% |
| 3 Month Change | 55.18% |
| 1 Year Change | 8.18% |
| 3 Year Change | 125.10% |
| 5 Year Change | 103.31% |
| Change since IPO | 6,385.45% |
Noticias y actualizaciones recientes
Recent updates
Abiomed (NASDAQ:ABMD) Has More To Do To Multiply In Value Going Forward
Oct 24
Abiomed's Impella low profile sheath gets FDA clearance
Oct 17Abiomed: Correction Offers Good Buying Opportunity
Sep 28U.S. FDA gives two approvals to Abiomed Impella heart pumps
Sep 16What Does Abiomed, Inc.'s (NASDAQ:ABMD) Share Price Indicate?
Sep 13Abiomed FQ1 2023 Earnings Preview
Aug 03Returns On Capital At Abiomed (NASDAQ:ABMD) Have Stalled
Jul 11Abiomed's Profit Growth Slows On R&D, Sales Hold Strong Despite Shortages
May 17Is Abiomed (NASDAQ:ABMD) A Risky Investment?
Mar 17Abiomed's Less Troubled 2020 Justifies Multiple, But Medium-Term Headwinds Mean Capital Risk
Jan 24The Returns At Abiomed (NASDAQ:ABMD) Aren't Growing
Jan 04These 4 Measures Indicate That Abiomed (NASDAQ:ABMD) Is Using Debt Safely
Dec 14Abiomed: Impella Will Continue To Drive Revenue Growth
Sep 10Here's What To Make Of Abiomed's (NASDAQ:ABMD) Decelerating Rates Of Return
Sep 01Abiomed: Recovery Mode Has Been Activated - Reiterate Buy Rating
Jul 13At US$335, Is It Time To Put Abiomed, Inc. (NASDAQ:ABMD) On Your Watch List?
Jul 08DSMB recommends Abiomed trial for heart pump in cardiogenic shock continue
Jun 08Abiomed acquires preCARDIA a company targeting acute heart failure
Jun 01Here's Why I Think Abiomed (NASDAQ:ABMD) Might Deserve Your Attention Today
May 16Boston Scientific’s new clinical trial can impact Abiomed: Raymond James
May 06Abiomed FQ4 2021 Earnings Preview
Apr 28Should You Investigate Abiomed, Inc. (NASDAQ:ABMD) At US$315?
Apr 02Abiomed, Inc.'s (NASDAQ:ABMD) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Mar 12Has Abiomed (NASDAQ:ABMD) Got What It Takes To Become A Multi-Bagger?
Feb 18Results: Abiomed, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Jan 31Rentabilidad de los accionistas
| ABMD | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 0.005% | 1.4% | 1.2% |
| 1Y | 8.2% | -0.7% | 24.7% |
Rentabilidad vs. Industria: ABMD exceeded the US Medical Equipment industry which returned -23.7% over the past year.
Rentabilidad vs. Mercado: ABMD exceeded the US Market which returned -22.8% over the past year.
Volatilidad de los precios
| ABMD volatility | |
|---|---|
| ABMD Average Weekly Movement | 14.6% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: ABMD's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: ABMD's weekly volatility has increased from 9% to 15% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1981 | 2,003 | Mike Minogue | www.abiomed.com |
Resumen de fundamentos de Abiomed, Inc.
| Estadísticas fundamentales de ABMD | |
|---|---|
| Capitalización bursátil | US$17.19b |
| Beneficios(TTM) | US$266.76m |
| Ingresos (TTM) | US$1.07b |
64.4x
Ratio precio-beneficio (PE)16.0x
Ratio precio-ventas (PS)¿Está ABMD sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ABMD | |
|---|---|
| Ingresos | US$1.07b |
| Coste de los ingresos | US$200.59m |
| Beneficio bruto | US$873.51m |
| Otros gastos | US$606.74m |
| Beneficios | US$266.76m |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 5.91 |
| Margen bruto | 81.32% |
| Margen de beneficio neto | 24.84% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado ABMD a largo plazo?
Ver rendimiento histórico y comparativa